In early 2019, the American Society of Health-System Pharmacists (ASHP) reported a nationwide shortage of certain intravenous immunoglobulin (IVIG) therapies, which has now led to national shortages of all IVIG products. Supply limitations have affected all healthcare providers who administer these therapies, including Infusion Express. At this time, Infusion Express is unable to accept new IVIG patients.
Infusion Express will continue to accommodate existing patients but cannot guarantee product availability. To proactively inquire about a previously scheduled IVIG appointment, please contact your local center.
Gammagard is an IVIG infusion therapy that is indicated to treat:
- primary humoral immunodeficiency disease (PIDD) in patients two years of age or older
- multifocal motor neuropathy (MMN)
Gammagard is an IVIG therapy that uses antibodies collected from the plasma of healthy people to replace the missing antibodies in primary immunodeficiency (PI) patients. It also can be used as a maintenance therapy to improve muscle strength and disability in adult patients with multifocal motor neuropathy (MMN). For PI patients, infusions are given every three-four weeks for typically 30 minutes and can be increased as tolerated. For MMN patients, infusions are given monthly for typically an hour each time.
Patients chose Infusion Express to receive their ongoing Gammagard treatments because:
- ALL private suites
- Comfortable recliners, with chairs for guests
- Evening & weekend appointments
- Friendly clinical staff deliver personal service
- Big screen TVs, high-speed WiFi, free snacks